Miruvor

BC 007 / rovunaptabin

5 people describe trying BC 007 / rovunaptabin, all with long COVID.

40%
recovered fully or nearly
2 of 5
60%
improved (substantial or partial)
3 of 5
0%
relapsed
0 of 5
0%
no benefit
0 of 5

How it went

Did it last?

  • 1 of 5 said the benefit wore off.
  • No one said they needed to keep it up to stay well.

Read from what people wrote. A story that ends without a follow-up counts as lasting, so treat these as minimums.

Outcome describedAccountsShare
Full recovery240%
Near-full00%
Substantial240%
Partial120%
Relapsed00%
No benefit00%

Only 5 accounts. Treat these percentages as anecdotes, not rates.

By how ill people were

Severity at worstHow it wentnRecovered
Severe250%
Very severe10%

2 accounts don’t say how ill the person was.

Who published these accounts

Independent (blog, forum, news)5 accounts
40%

Right-hand number: share describing a full or near-full recovery. Pages that sell something, and advocacy sites, tend to publish only the successes.

All 5 accounts

  • Berlin Cures' failed trial (Emma)

    Partial Long COVID thesicktimes.org Jul 2025

    Emma took part in the same Berlin Cures trial of BC 007 (rovunaptabin), though the article does not specify her dose or whether she received the active drug or placebo, nor how severe or long-standing her Long COVID was. She reported that her symptoms…

  • Berlin Cures' failed Long COVID clinical trial yields lessons on study design

    Substantial Long COVID Severe thesicktimes.org Jul 2025

    Shayna Bhalla received BC 007 (rovunaptabin) infusions as part of the Berlin Cures Long COVID trial, though the article does not give the specific dose, frequency, or duration of infusions. She had lived with Long COVID for years, with fatigue, headaches and…

  • Berlin Cures? Could BC 007 Help With Long COVID and ME/CFS? (glaucoma)

    Full recovery Long COVID healthrising.org Dec 2021

    This long-COVID patient, who also had glaucoma, received a single infusion of BC 007, though the page does not give the dose or infusion length for this case. Her long COVID symptoms cleared up afterward, an outcome that helped prompt Berlin Cures' broader…

  • Berlin Cures? Could BC 007 Help With Long COVID and ME/CFS? (exerciser)

    Substantial Long COVID Very severeEffect faded healthrising.org Dec 2021

    This avid exerciser received a single 75-minute BC 007 IV infusion with three days of hospital monitoring, after long COVID had left the person bedridden with episodes of temporary paralysis and unable to follow conversations. The infusion produced a marked,…

  • Berlin Cures? Could BC 007 Help With Long COVID and ME/CFS? (skier)

    Full recovery Long COVID Severe healthrising.org Dec 2021

    This cross-country skier and former Ironman athlete received a single 75-minute IV infusion of the investigational drug BC 007, with three days of hospital monitoring afterward, months after a COVID infection had left him severely debilitated, disoriented…